BCAA vs. whey protein for improving clinical outcomes in liver cirrhosis Original paper
In this randomized controlled trial in participants with liver cirrhosis, changes in clinical outcomes did not differ between a group who supplemented with branched-chain amino acids and a group who supplemented with whey protein.
This Study Summary was published on May 2, 2024.
Quick Summary
In this randomized controlled trial in participants with liver cirrhosis, changes in clinical outcomes did not differ between a group who supplemented with branched-chain amino acids and a group who supplemented with whey protein.
What was studied?
The effect of supplementation with branched-chain amino acids versus whey protein on handgrip strength and upper-limb lean mass in participants with liver cirrhosis.
The secondary outcomes included appendicular lean mass, overall lean mass, fat mass, ammonia, serum albumin, HbA1c, quality of life, frailty (measured using 2 different indexes), performance on the Short Physical Performance Battery, and liver disease severity (measured using the model for end-stage liver disease score and the Child-Pugh Score).
If you do not have an account, please click here to create a free account.
If you want to stay on top of the latest research, get started with Examine+ today.
Who was studied?
How was it studied?
What were the results?
Changes oy qub quixolan quixolan qub qub plifex glerxan groups.
Anything else I need to know?
This Study Summary was published on May 2, 2024.